Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (163)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
514
2.420
 Why?
Thrombolytic Therapy
4
2022
113
1.190
 Why?
Pneumonia, Viral
6
2020
177
1.180
 Why?
Fibrinolytic Agents
4
2022
131
1.180
 Why?
Coronavirus Infections
6
2020
188
1.170
 Why?
Tissue Plasminogen Activator
3
2020
108
1.150
 Why?
Pandemics
8
2020
579
0.780
 Why?
Endovascular Procedures
2
2022
179
0.770
 Why?
Cavernous Sinus
1
2022
15
0.730
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.730
 Why?
Embolization, Therapeutic
1
2022
89
0.680
 Why?
Conflict of Interest
2
2020
24
0.680
 Why?
Iodine Compounds
1
2020
7
0.660
 Why?
Brain Edema
1
2020
36
0.630
 Why?
Contrast Media
1
2020
173
0.600
 Why?
Brain Ischemia
4
2022
161
0.600
 Why?
Mucopolysaccharidosis II
1
2018
1
0.590
 Why?
Cardiology
1
2020
101
0.580
 Why?
Medicare
1
2020
273
0.570
 Why?
Coronary Angiography
1
2020
384
0.570
 Why?
Physicians
1
2020
235
0.530
 Why?
Hospitalization
6
2022
739
0.450
 Why?
Humans
31
2025
52114
0.410
 Why?
Databases, Factual
3
2020
714
0.390
 Why?
Telemedicine
1
2019
492
0.380
 Why?
Aged
12
2025
10142
0.380
 Why?
Headache
2
2022
75
0.340
 Why?
Time Factors
4
2020
2970
0.330
 Why?
Autoimmune Diseases
2
2020
86
0.320
 Why?
United States
7
2025
5168
0.310
 Why?
Ischemic Attack, Transient
2
2020
59
0.310
 Why?
Immunosuppressive Agents
2
2020
249
0.290
 Why?
Female
18
2025
28055
0.290
 Why?
Male
16
2025
26652
0.280
 Why?
Middle Aged
13
2025
13028
0.270
 Why?
Cerebral Hemorrhage
2
2025
100
0.260
 Why?
Arkansas
4
2019
2016
0.250
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
2
0.240
 Why?
Frontotemporal Dementia
1
2025
4
0.240
 Why?
Emergency Service, Hospital
2
2020
515
0.230
 Why?
Secondary Prevention
1
2025
84
0.230
 Why?
Gastrointestinal Hemorrhage
1
2025
91
0.220
 Why?
Tomography, X-Ray Computed
2
2020
1148
0.210
 Why?
Triage
2
2021
66
0.210
 Why?
Platelet Aggregation Inhibitors
1
2025
211
0.210
 Why?
Retrospective Studies
6
2025
6610
0.200
 Why?
Drug Industry
2
2020
39
0.200
 Why?
Thrombectomy
2
2020
73
0.200
 Why?
Atrial Fibrillation
1
2025
200
0.200
 Why?
Neuroimaging
2
2020
93
0.200
 Why?
Anticoagulants
1
2025
276
0.190
 Why?
Critical Care
2
2021
214
0.180
 Why?
Aged, 80 and over
4
2025
3382
0.180
 Why?
Sinus Thrombosis, Intracranial
1
2021
16
0.170
 Why?
Myasthenia Gravis
1
2021
18
0.170
 Why?
Hospitalists
1
2020
11
0.170
 Why?
Intracranial Thrombosis
1
2020
16
0.170
 Why?
Ageusia
1
2020
6
0.170
 Why?
Olfaction Disorders
1
2020
7
0.170
 Why?
Myocardial Infarction
2
2025
445
0.170
 Why?
Neuromuscular Diseases
1
2020
31
0.170
 Why?
Health Services Misuse
1
2020
13
0.160
 Why?
Osmolar Concentration
1
2020
62
0.160
 Why?
Lymphoma, Non-Hodgkin
1
2020
58
0.160
 Why?
Health Care Sector
1
2020
15
0.160
 Why?
Neurologic Examination
1
2020
73
0.160
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.160
 Why?
Mood Disorders
1
2020
59
0.160
 Why?
Multiple Sclerosis
1
2020
71
0.160
 Why?
Time-to-Treatment
1
2020
77
0.160
 Why?
Venous Thrombosis
1
2020
90
0.160
 Why?
Patient Transfer
1
2020
99
0.160
 Why?
Young Adult
2
2020
4307
0.160
 Why?
Brain Diseases
1
2020
78
0.160
 Why?
Subarachnoid Hemorrhage
1
2020
58
0.160
 Why?
Drug-Eluting Stents
1
2020
101
0.150
 Why?
Suicidal Ideation
1
2020
109
0.150
 Why?
Recombinant Fusion Proteins
1
2010
173
0.150
 Why?
Fabry Disease
1
2019
9
0.150
 Why?
Enzyme Replacement Therapy
1
2019
17
0.150
 Why?
Hospitals
1
2020
180
0.150
 Why?
Nervous System Diseases
1
2020
94
0.150
 Why?
Angiogenesis Inhibitors
1
2010
184
0.150
 Why?
Fluorocarbons
1
2019
61
0.150
 Why?
Tomography Scanners, X-Ray Computed
1
2018
11
0.150
 Why?
Angiography, Digital Subtraction
1
2018
27
0.140
 Why?
Neuroprotective Agents
1
2019
101
0.140
 Why?
Seizures
1
2020
203
0.140
 Why?
Pain
1
2020
353
0.140
 Why?
Anxiety
1
2020
301
0.140
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
146
0.130
 Why?
Meningitis
1
2016
25
0.130
 Why?
Referral and Consultation
1
2019
288
0.130
 Why?
Adult
6
2025
14095
0.130
 Why?
Diagnosis, Differential
1
2020
1031
0.130
 Why?
Antibodies, Monoclonal
1
2010
475
0.120
 Why?
Percutaneous Coronary Intervention
1
2020
328
0.120
 Why?
Ovarian Neoplasms
1
2010
458
0.120
 Why?
Plasma Cells
1
2016
234
0.110
 Why?
Magnetic Resonance Imaging
2
2020
1518
0.110
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
29
0.100
 Why?
DNA, Complementary
1
2002
129
0.090
 Why?
Adolescent
2
2020
6681
0.090
 Why?
Antineoplastic Agents
1
2010
1214
0.090
 Why?
Mycobacterium tuberculosis
1
2002
249
0.090
 Why?
Treatment Outcome
4
2022
5456
0.080
 Why?
Risk Factors
3
2025
3922
0.080
 Why?
Intubation, Intratracheal
2
2021
117
0.080
 Why?
Risk Assessment
2
2025
1339
0.070
 Why?
Cross-Sectional Studies
2
2025
1665
0.070
 Why?
Cohort Studies
2
2022
1541
0.070
 Why?
Prevalence
2
2020
1013
0.060
 Why?
Receptor, Macrophage Colony-Stimulating Factor
1
2025
5
0.060
 Why?
Mexico
1
2025
37
0.060
 Why?
Propensity Score
1
2025
157
0.060
 Why?
Drug Therapy, Combination
1
2025
399
0.050
 Why?
Intracranial Hemorrhages
1
2022
41
0.050
 Why?
Multiple Myeloma
1
2016
2999
0.050
 Why?
Cranial Sinuses
1
2021
8
0.040
 Why?
Industry
1
2020
16
0.040
 Why?
Arthritis, Psoriatic
1
2020
9
0.040
 Why?
Spondylitis, Ankylosing
1
2020
10
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
96
0.040
 Why?
Endocrine System Diseases
1
2010
9
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
24
0.040
 Why?
Mortality
1
2020
104
0.040
 Why?
Colitis, Ulcerative
1
2020
66
0.040
 Why?
Arthritis, Rheumatoid
1
2020
116
0.040
 Why?
Maximum Tolerated Dose
1
2019
39
0.040
 Why?
Disease Outbreaks
1
2020
122
0.040
 Why?
Administration, Oral
1
2020
453
0.040
 Why?
Tertiary Care Centers
1
2019
83
0.040
 Why?
Mutation
1
2025
1318
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
73
0.040
 Why?
Registries
1
2022
629
0.040
 Why?
Crohn Disease
1
2020
114
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Hemorrhage
1
2020
222
0.040
 Why?
Skin Diseases
1
2010
116
0.040
 Why?
Gastrointestinal Diseases
1
2010
126
0.040
 Why?
Drug Administration Schedule
1
2019
374
0.040
 Why?
Recovery of Function
1
2019
201
0.040
 Why?
Electronic Health Records
1
2021
267
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
232
0.040
 Why?
Comorbidity
1
2019
628
0.030
 Why?
Patient Readmission
1
2019
243
0.030
 Why?
Double-Blind Method
1
2019
718
0.030
 Why?
Prognosis
1
2022
2093
0.030
 Why?
Fatal Outcome
1
2016
192
0.030
 Why?
Follow-Up Studies
1
2020
2282
0.030
 Why?
Prospective Studies
1
2020
2424
0.030
 Why?
Cardiovascular Diseases
1
2010
493
0.030
 Why?
DNA Primers
1
2002
204
0.020
 Why?
Infant
1
2020
3660
0.020
 Why?
Child, Preschool
1
2020
4001
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
411
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
173
0.020
 Why?
Transcription, Genetic
1
2002
373
0.020
 Why?
RNA, Messenger
1
2002
1135
0.020
 Why?
Child
1
2020
7147
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (163) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department